Editorial

The impact of Covid-19 on pharmaceutical companies worldwide

The covid-19 disruption created a challenging environment that made the global market handicapped due to supply and demand issues. The IQVIA2019 Global Use of Medicine report revealed that people’s spending on medicine would exceed $1.4 trillion by 2021.

The Pharma industry is facing multiple challenging happening due to the coronavirus pandemic and antimicrobial resistance. On the other hand, we know that the challenge will birth new opportunities. The Pharma industry is evolving by facing the challenging occurring in the pandemic.

Many companies began to work on team efficiency, high-tech investment and research programs to improve in the future. Life Science companies are refining their production cycle, cloud technology, machine learning and digital investments.

It will help them identify drugs in specific conditions and do the budget-friendly trials of drugs to get the results. Generate the health-related data more accurately.

Pharma industry on its way-taking rebirth

The Pharma sector is dealing with the complication coming in the pandemic. Therefore, it has brought some revolutionary changes in the healthcare sector from the population encouraged towards health and wellness understanding its benefits, life science companies performing medicine trials efficiently, drug designs and bringing innovation by using the latest cloud-based technologies and digital payment system. The new developments give personalized focus on reshaping, reforming the healthcare sector, and getting positive changes.

Sailing in the challenging crisis days

We all equally suffered in the crisis. The pharma companies managed to come from the problem astonishingly to deal with the situation in a responsive way. Pharma fraternity worked on their weak spots and tried to make their digital presence in the crucial times. They collaborated with the right service providers that helped them run smoothly during the crisis management process. Many companies across the world face issues related to event cancellations. However, it prevented the pharma companies from launching their new products. The pharma sector digitalization incorporated managing the crisis and then plans the processes for growth.

Food Supplements Demand

Patients start inclining towards the healthy food supplements with the increase of the lifestyle diseases. 63% of these products are available on the prescription of the pharmacists. There is an increase in the demand for nutritional supplements. It compensates for the lifestyle-related problems of the people. It is beneficial for them to motivate them towards preventive healthcare and internet penetration outflow. The worth of the nutraceutical market in India by 2022 is around $8.5 billion accounting for 3% of growth. It is a lucrative market to tap now and in the future years too.

Collaboration Pharma Companies & Ecommerce Sector is making medicine delivery possible anytime.

We know that the e-commerce sector is becoming a booming industry. Pharma industries are creating attractive revenue for them with the launch of E-pharmacy. It ensured that the patients received the medicines during the lockdown imposed due to the outbreak of the coronavirus pandemic. The rapid internet penetration helped the patients get the proper medical facilities clinical trials, blood availability online, getting approvals for drug testing, medical records, information exchange, vaccines, diagnosis and vaccines.

Related Articles

Back to top button